Key statistics
On Friday, Phathom Pharmaceuticals Inc (PHAT:NSQ) closed at 7.95, 259.73% above the 52 week low of 2.21 set on May 08, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.47 |
---|---|
High | 8.54 |
Low | 7.91 |
Bid | 7.99 |
Offer | 8.04 |
Previous close | 8.32 |
Average volume | 938.14k |
---|---|
Shares outstanding | 69.81m |
Free float | 57.39m |
P/E (TTM) | -- |
Market cap | 580.85m USD |
EPS (TTM) | -5.24 USD |
Data delayed at least 15 minutes, as of Jul 18 2025 21:00 BST.
More ▼
- Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary
- Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032
- Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032
- Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
- Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
- Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2025 Annual Meeting
- Phathom Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide Business Update on Thursday, May 1, 2025
- Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors
More ▼